170 related articles for article (PubMed ID: 24091029)
21. Expression of vascular endothelial growth factor receptor Flk-1 in canine mammary tumours.
Restucci B; Borzacchiello G; Maiolino P; Martano M; Paciello O; Papparella S
J Comp Pathol; 2004; 130(2-3):99-104. PubMed ID: 15003465
[TBL] [Abstract][Full Text] [Related]
22. Expression of vascular endothelial growth factor in canine mammary tumors.
Restucci B; Papparella S; Maiolino P; De Vico G
Vet Pathol; 2002 Jul; 39(4):488-93. PubMed ID: 12126152
[TBL] [Abstract][Full Text] [Related]
23. The prognostic significance of angiogenesis in canine mammary tumors.
Graham JC; Myers RK
J Vet Intern Med; 1999; 13(5):416-8. PubMed ID: 10499723
[TBL] [Abstract][Full Text] [Related]
24. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
25. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer.
Clemente M; Pérez-Alenza MD; Illera JC; Peña L
Vet Pathol; 2010 Mar; 47(2):265-74. PubMed ID: 20106772
[TBL] [Abstract][Full Text] [Related]
26. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
27. Relationship between the expression of versican and EGFR, HER-2, HER-3 and CD44 in matrix-producing tumours in the canine mammary gland.
Damasceno KA; Ferreira E; Estrela-Lima A; Bosco Y; Silva LP; Barros AL; Bertagnolli AC; Cassali GD
Histol Histopathol; 2016 Jun; 31(6):675-88. PubMed ID: 26666308
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of intratumoral microvessel density in canine soft-tissue sarcomas.
Luong RH; Baer KE; Craft DM; Ettinger SN; Scase TJ; Bergman PJ
Vet Pathol; 2006 Sep; 43(5):622-31. PubMed ID: 16966439
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of galectin-1 and galectin-3 in canine non-malignant and malignant mammary tissues and in progression to metastases in mammary tumors.
DE Oliveira JT; DE Matos AJ; Barros R; Ribeiro C; Chen A; Hespanhol V; Rutteman GR; Gärtner F
Anticancer Res; 2014 May; 34(5):2211-21. PubMed ID: 24778023
[TBL] [Abstract][Full Text] [Related]
30. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of transforming growth factor β (TGFβ) and latent TGFβ binding protein (LTBP)-4 expression in late stage canine mammary tumours.
Klopfleisch R; Schütze M; Gruber AD
Vet J; 2010 Dec; 186(3):379-84. PubMed ID: 19836277
[TBL] [Abstract][Full Text] [Related]
32. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops.
Millanta F; Silvestri G; Vaselli C; Citi S; Pisani G; Lorenzi D; Poli A
Res Vet Sci; 2006 Dec; 81(3):350-7. PubMed ID: 16556453
[TBL] [Abstract][Full Text] [Related]
33. Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?
Ek ET; Ojaimi J; Kitagawa Y; Choong PF
Oncol Rep; 2006 Jul; 16(1):17-23. PubMed ID: 16786118
[TBL] [Abstract][Full Text] [Related]
34. Expression of Cox-1 and Cox-2 in canine mammary tumours.
Queiroga FL; Alves A; Pires I; Lopes C
J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
[TBL] [Abstract][Full Text] [Related]
35. MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study.
De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Dos Santos MS; Rutteman GR; Gärtner Mde F
Anticancer Res; 2006; 26(3A):1821-6. PubMed ID: 16827113
[TBL] [Abstract][Full Text] [Related]
36. Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumours.
Shiomitsu K; Johnson CL; Malarkey DE; Pruitt AF; Thrall DE
Vet Comp Oncol; 2009 Jun; 7(2):106-14. PubMed ID: 19453364
[TBL] [Abstract][Full Text] [Related]
37. Quantification of VEGF-C expression in canine mammary tumours.
Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
[TBL] [Abstract][Full Text] [Related]
38. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
[TBL] [Abstract][Full Text] [Related]
39. An analysis of microvessel density in salivary gland tumours: a single centre study.
Dhanuthai K; Sappayatosok K; Yodsanga S; Rojanawatsirivej S; Pausch NC; Pitak-Arnnop P
Surgeon; 2013 Jun; 11(3):147-52. PubMed ID: 22878098
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical analysis of urokinase plasminogen activator and its prognostic value in canine mammary tumours.
Santos A; Lopes C; Marques RM; Amorim I; Ribeiro J; Frias C; Vicente C; Gärtner F; de Matos A
Vet J; 2011 Jul; 189(1):43-8. PubMed ID: 20598596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
